Axxion S.A.’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Axxion S.A.'s BIIB Position: Q3 2026 in Review
Axxion S.A. reduced its Biogen (BIIB) stake by 25% in Q3 2026, selling an estimated $117K and leaving 1,650 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #268.
Axxion S.A. first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. The position peaked at $475K in Q2 2026. 1,057 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Axxion S.A. held 1,650 shares of Biogen worth $373K as of Q3 2026.
- Axxion S.A. sold 550 Biogen shares in Q3 2026, an estimated $117K.
- Biogen made up 0.02% of Axxion S.A.'s portfolio in Q3 2026, its #268 holding.
- Axxion S.A. first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
- Axxion S.A.'s Biogen position peaked at $475K in Q2 2026.
- 1,057 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.